Last reviewed · How we verify

NCT05773521: PAMAL

Peri-operative Analgesia for Single-incision Laparoscopic Appendectomy

Status unknown Last updated 14 August 2023
What this trial tests

trial testing SILAP (single incision laparoscopic appendectomy) in Appendicitis in 140 participants. Status unknown.

Timeline
31 August 2023
Primary endpoint
31 October 2023
31 December 2023

Quick facts

Lead sponsorUniversity Hospital, Angers
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment140
Start date31 August 2023
Primary completion31 October 2023
Estimated completion31 December 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

Adults 1 Day to 15, any sex, with Appendicitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic appendectomy is a very common intervention in pediatric surgery. To improve outcomes, some teams have developed the use of single-site laparoscopic appendectomy (SILAP). Nevertheless, there is no consensus yet and no published data on the better perioperative analgesia, and different modalities including general intravenous analgesia, locoregional pre-operative analgesia and local analgesia can be used.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Appendicitis

Currently open trials in the same condition.

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05773521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing